3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
12
Gastrointestinal
11
Genitourinary
8
Thoracic
6
Other hematologic neoplasm
3
Lymphoid
3
Plasma cell
1
Head & Neck
1
Endocrine
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
3102
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2086
Leukemia
2013
Leukemia, Lymphocytic, Chronic, B-Cell
1771
Myelodysplastic Syndromes
1298
Hematologic Neoplasms
1067
Lymphoma
1029
Lymphoma, Non-Hodgkin
981
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
713
Lymphoma, Follicular
704
Lymphoma, Mantle-Cell
678
Lymphoma, Large B-Cell, Diffuse
657
Burkitt Lymphoma
642
Multiple Myeloma
639
Lymphoma, B-Cell, Marginal Zone
599
Recurrence
587
Hodgkin Disease
575
Leukemia, Myelomonocytic, Chronic
495
Lymphoma, Large-Cell, Immunoblastic
419
Neoplasms
402
Myeloproliferative Disorders
402
Leukemia, Myeloid, Chronic-Phase
391
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
382
Congenital Abnormalities
357
Waldenstrom Macroglobulinemia
330
Blast Crisis
324
Leukemia, Myeloid, Accelerated Phase
290
Lymphoma, T-Cell, Cutaneous
280
Primary Myelofibrosis
270
Anemia, Refractory, with Excess of Blasts
251
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Interventional
×
Communication
×
Other hematologic neoplasm
×
Clear all
NCT05335369
2026-05-11
UR-GOAL 2
University of Rochester
Phase NA
Completed
161 enrolled
19 charts
NCT06102330
2025-08-03
HomeVENT
Johns Hopkins University
Phase NA
Recruiting
600 enrolled
NCT06376188
2024-04-19
SimCom
Medical University of Vienna
Phase NA
Completed
46 enrolled